Pregled bibliografske jedinice broj: 865998
Trichoplaxin - a new membrane-active antimicrobial peptide from placozoan cDNA
Trichoplaxin - a new membrane-active antimicrobial peptide from placozoan cDNA // Biochimica et biophysica acta. Biomembranes, 1838 (2014), 1430-1438 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 865998 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Trichoplaxin - a new membrane-active antimicrobial peptide from placozoan cDNA
(Trichoplaxin - a new membrane-active antimicrobial peptide from placozoan cDNA.)
Autori
Simunić, Juraj ; Petrov, Dražen ; Bouceba, Tahar ; Kamech, Nedia ; Benincasa, Monica ; Juretić, Davor
Izvornik
Biochimica et biophysica acta. Biomembranes (0005-2736) 1838
(2014);
1430-1438
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Antimicrobial peptide ; EST database ; Trichoplax adhaerens ; Selectivity index ; Surface plasmon resonance ; Peptide–membrane interaction
Sažetak
A method based on the use of signal peptide sequences from antimicrobial peptide (AMP) precursors was used to mine a placozoa expressed sequence tag database and identified a potential antimicrobial peptide from Trichoplax adhaerens. This peptide, with predicted sequence FFGRLKSVWSAVKHGWKAAKSR is the first AMP from a placozoan species, and was named trichoplaxin. It was chemically synthesized and its structural properties, biological activities and membrane selectivity were investigated. It adopts an α-helical structure in contact with membrane-like environments and is active against both Gram-negative and Gram-positive bacterial species (including MRSA), as well as yeasts from the Candida genus. The cytotoxic activity, as assessed by the haemolytic activity against rat erythrocytes, U937 cell permeabilization to propidium iodide and MCF7 cell mitochondrial activity, is significantly lower than the antimicrobial activity. In tests with membrane models, trichoplaxin shows high affinity for anionic prokaryote-like membranes with good fit in kinetic studies. Conversely, there is a low affinity for neutral eukaryote-like membranes and absence of a dose dependent response. With high selectivity for bacterial cells and no homologous sequence in the UniProt, trichoplaxin is a new potential lead compound for development of broad- spectrum antibacterial drugs.
Izvorni jezik
Engleski
Znanstvena područja
Biologija
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus